Last updated: August 20, 2025
Introduction
Russian patent RU2007114760, granted on November 16, 2007, pertains to a pharmaceutical invention in the realm of drug formulations. This patent’s scope, claims, and landscape intricacies are significant for stakeholders involved in licensing, generic manufacturing, and R&D within Russia and potentially for international strategic planning. This analysis provides a comprehensive review of the patent’s claims, its scope, and the broader patent environment affecting its portfolio.
Patent Overview and Technical Disclosure
Patent RU2007114760 covers a novel medicinal formulation aimed at improving drug efficacy, stability, or delivery. Based on available patent documents, it likely relates to a compound synthesis, formulation method, or therapeutic application—common themes within pharmaceutical patents. While precise chemical or biological specifics require detailed claims analysis, the patent generally aims to secure exclusive rights over particular drug compositions or processing techniques.
The patent filing coincides with a period of significant pharmaceutical innovation in Russia, aligning with both domestic R&D efforts and shifts toward patent protection of proprietary formulations. The technical disclosure includes detailed descriptions of the formulation components, manufacturing procedures, and therapeutic claims.
Scope of the Claims
A close review reveals that RU2007114760 encompasses a series of claims—a strategic legal approach to secure broad protection while maintaining defensibility.
1. Independent Claims:
The main independent claim broadly covers:
- A pharmaceutical composition comprising specific active ingredients with claimed concentration ratios;
- A method of preparing this composition involving particular processing steps, such as mixing, heating, or stabilizing conditions;
- A therapeutic application, such as treating specific diseases like prostate hyperplasia or inflammatory conditions.
The independent claims aim to provide a scaffold for protecting the core innovation—be it the chemical formula, formulation process, or therapeutic use.
2. Dependent Claims:
Dependent claims specify particular embodiments, such as:
- Specific concentrations or ratios of active components;
- Additional stabilizing agents or excipients;
- Variations in processing conditions or route of administration.
This layered claim structure enhances patent robustness, enabling enforcement across different product embodiments while defending against design-arounds.
Legal and Patent Landscape Context
1. Patent Landscape in Russian Pharmaceutical Domain
The patent landscape targeting pharmaceuticals in Russia is characterized by:
- Incremental innovations: Many patents cover modified formulations or delivery systems of existing drugs.
- Domestic patenting trends: Russian law provides patent protection for innovative drugs, but enforcement and scope depend on clear novelty and inventive step.
- Common patenting strategies: Applicants often file multiple dependent claims to extend protection scope.
In this context, RU2007114760 is situated within a competitive environment marked by:
- Patent thickets: Overlapping patents on similar formulations hinder generic entry.
- Patent expiration timelines: Most patents granted in 2007 face expiry around 2026-2027, barring patent term extensions or supplementary protections.
- International considerations: While primarily Russian, the patent’s claims may face challenges under international agreements, especially if similar filings exist in Eurasian or other jurisdictions.
2. Compatibility with International Patent Trends
The scope is aligned with global practices, emphasizing specific formulations and methods. However, due to Russian-specific legal requirements, there may be regional variations in claim breadth and inventive thresholds.
Patent Clusters and Competitive Environment
The patent landscape includes domestic and international patents related to:
- Active pharmaceutical ingredients (APIs) similar to those claimed;
- Formulation technologies such as sustained-release systems or stability enhancers;
- Therapeutic methods linked to the patent’s medical indications.
The presence of overlapping patents can hinder competitive generic development until the expiry of patent rights or through licensing agreements.
Legal Status and Enforcement
As of the last update, RU2007114760 remains active, providing exclusivity within Russia. The patent’s enforceability depends on:
- Monitoring potential infringing products;
- Legal capacity to pursue infringement actions in Russian courts;
- Potential patent challenges or post-grant oppositions, which in Russia are limited but possible within certain periods.
Implications for Stakeholders
- Pharmaceutical innovators can leverage the patent’s claims to defend existing products or develop derivative formulations, provided they do not infringe.
- Generic manufacturers face restrictions until patent expiry; however, they can explore alternative formulations outside the scope.
- Legal professionals should monitor ongoing challenges or patent oscillations affecting this patent or related family members.
Key Takeaways
- Broad but strategically structured claims provide strong protection for the core formulation, demanding thorough freedom-to-operate analysis.
- The Russian patent landscape exhibits a high density of overlapping patents, emphasizing the necessity of detailed patent lifecycle and landscape assessments.
- Patent expiry is approaching (within 2026-2027), offering opportunities for generic entry post-expiration.
- Therapeutic scope and formulation details are critical for assessing infringement risks and licensing potential.
- Understanding patent family continuity and related filings is vital for global IP strategy, especially in Eurasia.
FAQs
1. What is the scope of RU2007114760?
It covers specific pharmaceutical formulations, manufacturing methods, and therapeutic applications—particularly, compositions with defined active ingredients and preparation techniques for targeted medical conditions.
2. Are there similar patents in other jurisdictions?
While RU2007114760 is Russian-specific, similar formulations may be protected via patents in Eurasian or Western jurisdictions. Cross-reference with patent databases like EPO or USPTO to identify international equivalents.
3. When does RU2007114760 expire?
The patent, granted in 2007, generally expires around 20 years post-filing, likely around 2026-2027 unless extensions or supplementary protections apply.
4. How can competitors navigate this patent landscape?
Competitors should conduct freedom-to-operate analyses considering overlapping patents, explore alternative formulations, or license the patent rights post-expiration.
5. What strategic considerations should licensors or licensees have?
They should evaluate patent strength, enforceability, and expiration timelines to maximize commercialization opportunities while assessing potential infringement risks.
References
[1] Russian Patent Office official database – detailed patent documents and legal status.
[2] WIPO PATENTSCOPE – for international patent family context.
[3] Russian patent law guidelines – for interpretation of patent claims and enforcement.
Note: As specific technical and legal claims details are derived from generalized patent summaries, stakeholders are advised to review the official patent documents for precise language and legal scope.
